Stay updated on Tislelizumab vs Chemotherapy in Esophageal Cancer Clinical Trial
Sign up to get notified when there's something new on the Tislelizumab vs Chemotherapy in Esophageal Cancer Clinical Trial page.

Latest updates to the Tislelizumab vs Chemotherapy in Esophageal Cancer Clinical Trial page
- CheckyesterdayChange DetectedThe References section was updated to include the updated J Clin Oncol 2022 publication (RATIONALE-302) with revision v3.5.4, replacing the previous entry that contained an erratum and revision v3.5.3. This change ensures the study record reflects the current publication and investigators involved.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe page revision indicator has been updated from v3.5.2 to v3.5.3, reflecting a back-end or release update rather than a change to the study content.SummaryDifference0.0%

- Check30 days agoChange DetectedAdded the RATIONALE-302 citation with revision v3.5.2 (including the 2024 erratum) and removed the older revision v3.5.0.SummaryDifference0.1%

- Check59 days agoChange DetectedAdded the revision indicator: Revision: v3.5.0. Removed the previous revision label: Revision: v3.4.3.SummaryDifference0.0%

- Check66 days agoChange DetectedThe Publications section now includes a new citation for Ajani et al. (Adv Ther, 2026) and removes the prior 2025 online-ahead-of-print citation.SummaryDifference0.0%

- Check74 days agoChange DetectedRevision: v3.4.3 was added and v3.4.2 was removed.SummaryDifference0.0%

Stay in the know with updates to Tislelizumab vs Chemotherapy in Esophageal Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tislelizumab vs Chemotherapy in Esophageal Cancer Clinical Trial page.